Odyssey Group International, Inc.: Difference between revisions
>Chris Created page with "Odyssey Group International, Inc., a medical technology company, focuses on development, acquisition, and commercialization of medical products and health related technologies. It develops three lifesaving technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat concussions and rare brain disorders. The company was founded in 2014 and is headquartered in Irvine, Calif..." |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
== Summary == | |||
Odyssey Group International, Inc., a medical technology company, focuses on development, acquisition, and commercialization of medical products and health related technologies. It develops three lifesaving technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat concussions and rare brain disorders. The company was founded in 2014 and is headquartered in Irvine, California. | Odyssey Group International, Inc., a medical technology company, focuses on development, acquisition, and commercialization of medical products and health related technologies. It develops three lifesaving technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat concussions and rare brain disorders. The company was founded in 2014 and is headquartered in Irvine, California. | ||
__INDEX__ | |||
Latest revision as of 11:12, 20 August 2022
Summary edit edit source
Odyssey Group International, Inc., a medical technology company, focuses on development, acquisition, and commercialization of medical products and health related technologies. It develops three lifesaving technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat concussions and rare brain disorders. The company was founded in 2014 and is headquartered in Irvine, California.